UnitedHealth tops estimates, raises profit outlook amid high medical costs

• UnitedHealth's medical cost ratio came in at 88.4%, significantly better than the 89.9% analysts expected, indicating stronger profitability as the company collected more in premiums than paid out in benefits
• The company's value-based care initiatives are showing results: acute hospital admissions fell 15% year-over-year while home health admissions rose 10%, shifting patients to lower-cost care settings
• Medical costs remain elevated due to the No Surprises Act's dispute resolution process adding 1 percentage point to total costs, along with continued high expenses for inpatient services and specialty pharmacy drugs

Summary: UnitedHealth Tops Estimates, Raises Profit Outlook

Key Financial Results:

UnitedHealth Group exceeded Q3 expectations, reporting net income of $4.11 billion ($4.56 per share) on revenue of $112.69 billion versus the expected $111.40 billion. The company raised its fiscal 2026 adjusted earnings guidance to at least $20.50 per share.

Medical Cost Management:

The insurer's medical cost ratio improved significantly to 88.4%, beating analyst expectations of 89.9%. A lower ratio indicates stronger profitability as the company collects more in premiums relative to benefit payouts. However, CFO Wayne DeVeydt cautioned that medical costs remain "elevated versus historical norms."

Cost Pressures:

Key challenges include the independent dispute resolution (IDR) process under the No Surprises Act, adding approximately 100 basis points (1 percentage point) to total medical costs. Elevated expenses persist for inpatient services and specialty pharmacy drugs treating cancer and rare diseases.

Strategic Initiatives:

UnitedHealth's turnaround strategy focuses on:

• Shrinking membership and exiting unprofitable contracts
• Investing heavily in value-based care (tying provider compensation to patient outcomes rather than service volume)
• Deploying AI-powered tools to reduce administrative burden

Operational Improvements:

Results show acute hospital admissions dropped 15% year-over-year while home health admissions rose 10%, indicating successful patient migration to lower-cost care settings. Patient-initiated appointment scheduling increased 27% annually.

Market Implications:

The nation's largest private insurer demonstrates effective navigation of industry-wide challenges affecting Medicare Advantage plans. Management expects continued positive momentum from value-based care and AI investments through Q4 and into 2027, though elevated costs may ultimately translate to higher consumer premiums.